Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$12 Mln
P/E Ratio
--
P/B Ratio
0.34
Industry P/E
--
Debt to Equity
0.77
ROE
-1.7 %
ROCE
-94.04 %
Div. Yield
0 %
Book Value
--
EPS
--
CFO
$-458.55 Mln
EBITDA
$-457.62 Mln
Net Profit
$-569.21 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Bionano Genomics (BNGO)
| -75.15 | 30.30 | -41.02 | -90.58 | -83.94 | -54.00 | -- |
|
BSE Sensex
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|
|---|---|---|---|---|---|---|
|
Bionano Genomics (BNGO)
| -84.51 | -87.05 | -51.17 | -2.92 | 148.39 | -76.34 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 12.93 | 10,541.60 | 14.73 | 12.69 | |
| 72.80 | 9,636.16 | 93.23 | 2.52 | |
| 299.78 | 10,783.83 | 774.36 | 1.2 | |
| 117.67 | 14,455.82 | 41.45 | 5.44 |
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. The... company offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. It also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic data from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, the company offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California. Address: 9540 Towne Centre Drive, San Diego, CA, United States, 92121 Read more
President, CEO, Secretary & Director
Dr. Robert Erik Holmlin M.B.A., Ph.D.
President, CEO, Secretary & Director
Dr. Robert Erik Holmlin M.B.A., Ph.D.
Headquarters
San Diego, CA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Bionano Genomics Inc (BNGO) stood at $ 77 Mln as on 31-Dec-24
The share price of Bionano Genomics Inc (BNGO) is $4.30 (NASDAQ) as of 25-Apr-2025 16:00 EDT. Bionano Genomics Inc (BNGO) has given a return of -83.94% in the last 3 years.
Bionano Genomics Inc (BNGO) has a market capitalisation of $ 12 Mln as on 24-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Bionano Genomics Inc (BNGO) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Bionano Genomics Inc (BNGO) and enter the required number of quantities and click on buy to purchase the shares of Bionano Genomics Inc (BNGO).
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. The company offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. It also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic data from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, the company offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California. Address: 9540 Towne Centre Drive, San Diego, CA, United States, 92121
The CEO & director of Dr. Robert Erik Holmlin M.B.A., Ph.D.. is Bionano Genomics Inc (BNGO), and CFO & Sr. VP is Dr. Robert Erik Holmlin M.B.A., Ph.D..
There is no promoter pledging in Bionano Genomics Inc (BNGO).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,126
|
|
|
1,078
|
|
|
1,054
|
|
|
964
|
| Bionano Genomics Inc. (BNGO) | Ratios |
|---|---|
|
Return on equity(%)
|
-170.33
|
|
Operating margin(%)
|
-362.93
|
|
Net Margin(%)
|
-363.98
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Bionano Genomics Inc (BNGO) was $0 Mln.
$0.05
(
